Tradestie Institutional Equity Comparison Engine

IFLO vs ICUI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ICUI Overall Edge

ICUI Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ICU Medical Inc (ICUI) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IFLO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ICUI at 17.8x Forward P/E and 6.7% operating margin (+4.4% YoY). In options structure, IFLO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ICUI sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ICUI
IFLO N/M vs ICUI 17.8x Fwd P/E
Growth & Margin Winner ICUI
Op Margin N/A vs 6.7% ยท YoY N/A vs +4.4%
Momentum & Technical Winner ICUI
1Y +22.0% vs +30.1% ยท 52W Pos 63% vs 74%
Options & Structure Winner ICUI
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (2nd %ile IV)
IFLO NASDAQ
VictoryShares International Free Cash Flow ETF
Institutional Equity
$33.75
-2.02% 1D
Market Cap N/A
1M Return -6.34%
1Y Return +22.0%
Forward P/E N/M
Unified AI Score
35.7 / 100 SELL
Tech 8.0 Fund 42.0 Flow 50.0 Mom 46.1
ICUI NASDAQ
ICU Medical Inc
Surgical & Medical Instruments & Apparatus
$172.52
-1.84% 1D
Market Cap $4.4B
1M Return +2.49%
1Y Return +30.14%
Forward P/E 17.8x
Unified AI Score
49.5 / 100 HOLD
Tech 45.0 Fund 47.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IFLO +22.0% ICUI +30.14% Spread: +6.46 pp (ICUI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IFLO TTM Op. Margin: N/A ICUI TTM Op. Margin: 6.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IFLO vs ICUI. Trailing 12-month operating profitability (IFLO N/A vs ICUI 6.7%) and valuation multiples (IFLO N/M vs ICUI 17.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IFLO (1) vs ICUI (9)
Institutional Metric IFLO ICUI Criterion Row Winner
Market Capitalization Scale N/A $4.4B Larger Scale ICUI
Trailing P/E Ratio Valuation N/M 73.5x Lower Multiple ICUI
Forward P/E Ratio Valuation N/M 17.8x Lower Multiple ICUI
Revenue Growth (YoY) Growth N/A +4.4% Higher Growth ICUI
Operating Margin (TTM) Profitability N/A 6.7% Higher Margin ICUI
Net Profit Margin Profitability N/A 2.8% Higher Margin ICUI
Return on Equity (ROE) Capital Efficiency N/A 2.8% Higher ROE ICUI
52-Week Range Position Momentum 63% ($27โ€“$38) 74% ($113โ€“$193) Stronger Trend ICUI
Beta / 30D Volatility Risk Regime 0.76ฮฒ ยท 18% Vol 0.86ฮฒ ยท 38% Vol Lower Realized Risk IFLO
Unified Institutional Score Composite Signal 35.7 / 100 (SELL) 49.5 / 100 (HOLD) Higher Composite ICUI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IFLO vs ICUI Buy Guide
IFLO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IFLO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ICUI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live ICUI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IFLO nor ICUI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.